Showing results (541-550 of 15,740) with videos related to

Sort By:
Pageof 1,574
The Journal of Antimicrobial Chemotherapy|March 3, 1999
The in-vitro activity of HMR 3647, a new ketolide antimicrobial agentF J Boswell, J M Andrews, J P Ashby, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coliL J Piddock, Y F Jin, V Ricci, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Risk of resistance related to antibiotic use before admission in patients with community-acquired bacteraemiaG Pedersen, H C Schønheyder, F H Steffensen, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Study to assess the reliability of a disc diffusion method for determining the sensitivity of gram-positive pathogens to dalfopristin/quinupristinJ M Andrews, J P Ashby, R Wise
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Increasing fluoroquinolone resistance in salmonella serotypes in Finland during 1995-1997A Hakanen, A Siitonen, P Kotilainen, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 1999
The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopyD Honeybourne, J M Andrews, B Cunningham, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 1999
Bactericidal properties of moxifloxacin and post-antibiotic effectF J Boswell, J M Andrews, R Wise, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 1999
Pharmacokinetics of the 8-methoxyquinolone, moxifloxacin: tissue distribution in male ratsH M Siefert, C Kohlsdorfer, W Steinke, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 1999
Pharmacodynamics of trovafloxacin in experimental pneumococcal meningitis: basis for dosage selection in children with meningitisC C McCoig, L Wubbel, H S Jafri, et al.
The Journal of Antimicrobial Chemotherapy|June 26, 1999
Comparison of agar dilution, microdilution, Etest and disc diffusion to test the activity of trovafloxacin against Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniaeL M Kelly, M R Jacobs, P C Appelbaum
Pageof 1,574